Wednesday, January 25, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Policy + Initiatives

CONVINCE USA Aims to Address Public Concerns About COVID-19 Vaccine

by Global Biodefense Staff
December 2, 2020
CONVINCE USA Aims to Address Public Concerns About COVID-19 Vaccine

Credit: CUNY SPH

The City University of New York Graduate School of Public Health and Health Policy (CUNY SPH) today launched CONVINCE USA, part of a global project to increase understanding of factors that influence people’s willingness to accept new COVID-19 vaccines, and to promote inclusive public dialogue to reduce vaccine hesitancy.

As part of the global, multi-sector CONVINCEsm (COVID-19 New Vaccine Information Communication and Engagement) initiative with the Vaccine Confidence Project (VCP) at the London School of Hygiene & Tropical Medicine (LSHTM) and Wilton Park, CONVINCE USA will work at the national, state and local level, across the public, private and NGO sectors, and will include both independent and collaborative programs to create support for COVID-19 immunization and the science behind it.

“The need for our initiative is clear, given recent survey research that has identified high levels of potential refusal of a COVID-19 vaccine both here in New York City and nationally,” said Dr. Ayman El-Mohandes, Dean of CUNY SPH. “CONVINCE USA will be directed at CUNY SPH by its co-founder, Professor Scott Ratzan.”

Dr. Ratzan, Distinguished Lecturer at CUNY SPH and Editor of the Journal of Health Communication: International Perspectives, explained, “We have already been fortunate to obtain support from The Commonwealth Fund, CDC Foundation, and the Community Health Acceleration Partnership to undertake new research at CUNY SPH that will lead to the development of guidance to help public health workers and the private sector implement successful COVID-19 immunization campaigns, as approved vaccines become available in the coming months.”

An American Project within a Global Initiative

The CONVINCE USA project grew out of a series of global dialogues over the course of the pandemic with CUNY SPH, the VCP, and Wilton Park, an agency of the UK Foreign, Commonwealth, and Development Office.

“We look forward to using the insights on vaccine hesitancy that VCP has gathered globally over the last decade to help CONVINCE USA develop effective new communication and engagement strategies,” said Professor Heidi Larson, Director of the VCP.

The Wilton Park dialogues that provided the initial impetus for the CONVINCE initiative will continue to yield fresh insights and bring in new voices and ideas going forward. “We look forward to continuing to work with CUNY SPH and VCP to bring together larger, more diverse voices to understand the evolving dimensions of COVID-19 vaccine communication challenges,” said Nancy Lee, Programme Director for Global Health and Health Policy at Wilton Park. “Our goal is to find collaborative solutions that will help us all to break free of the pandemic and restore people’s lives and livelihoods.”

Tags: COVID CountermeasuresCOVID-19Editor PickSARS-CoV-2Vaccine OppositionVaccines

Related Posts

Liverpool Synthetic Biology Lab Backed By 2M Award
Policy + Initiatives

Political Interference: White House Launches Framework to Protect Scientific Integrity

January 13, 2023
Much of the CDC is Working Remotely. That Could Make Changing the Agency Difficult.
Policy + Initiatives

Much of the CDC is Working Remotely. That Could Make Changing the Agency Difficult.

December 7, 2022
Study: Cash Incentives and Lotteries Do Little to Increase Adult Vaccinations
Medical Countermeasures

Study: Cash Incentives and Lotteries Do Little to Increase Adult Vaccinations

October 25, 2022
Black Veterans Hospitalized with COVID-19 Less Likely to Receive Treatments Than White Veterans
Public Health

Black Veterans Hospitalized with COVID-19 Less Likely to Receive Treatments Than White Veterans

October 25, 2022
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC